Triani, F., Tramutola, A., Di Domenico, F., Sharma, N., Butterfield, D., Head, E., … Barone, E. (2018). Biliverdin reductase-A impairment links brain insulin resistance with increased Aβ production in an animal model of aging: Implications for Alzheimer disease. Biochimica et Biophysica Acta. Molecular Basis of Disease, 1864(10), 3181-3194. https://doi.org/10.1016/j.bbadis.2018.07.005
M Perluigi
First name:
M
Last name:
Perluigi
Tramutola, A., Triani, F., Di Domenico, F., Barone, E., Cai, J., Klein, J., … Butterfield, D. (2018). Poly-ubiquitin profile in Alzheimer disease brain. Neurobiology of Disease, 118, 129-141. https://doi.org/10.1016/j.nbd.2018.07.006
Tramutola, A., Sharma, N., Barone, E., Lanzillotta, C., Castellani, A., Iavarone, F., … Di Domenico, F. (2018). Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer’s disease. Biochimica et Biophysica Acta. Molecular Basis of Disease, 1864(10), 3309-3321. https://doi.org/10.1016/j.bbadis.2018.07.017
Barone, E., Tramutola, A., Triani, F., Calcagnini, S., Di Domenico, F., Ripoli, C., … Perluigi, M. (2019). Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease. Molecular Neurobiology, 56(4), 2922-2943. https://doi.org/10.1007/s12035-018-1231-5
Tramutola, A., Abate, G., Lanzillotta, C., Triani, F., Barone, E., Iavarone, F., … Uberti, D. (2018). Protein nitration profile of CD3<sup>+</sup> lymphocytes from Alzheimer disease patients: Novel hints on immunosenescence and biomarker detection. Free Radical Biology & Medicine, 129, 430-439. https://doi.org/10.1016/j.freeradbiomed.2018.10.414
Perluigi, M., Di Domenico, F., & Butterfield, D. (2015). mTOR signaling in aging and neurodegeneration: At the crossroad between metabolism dysfunction and impairment of autophagy. Neurobiology of Disease, 84, 39-49. https://doi.org/10.1016/j.nbd.2015.03.014
Sharma, N., Tramutola, A., Lanzillotta, C., Arena, A., Blarzino, C., Cassano, T., … Barone, E. (2019). Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer’s disease. Neurobiology of Disease, 125, 176-189. https://doi.org/10.1016/j.nbd.2019.02.003
Di Domenico, F., Tramutola, A., Barone, E., Lanzillotta, C., Defever, O., Arena, A., … Perluigi, M. (2019). Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome. Redox Biology, 23, 101162. https://doi.org/10.1016/j.redox.2019.101162
Lanzillotta, C., Di Domenico, F., Perluigi, M., & Butterfield, D. (2019). Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives. CNS Drugs, 33(10), 957-969. https://doi.org/10.1007/s40263-019-00658-8
Di Domenico, F., Perluigi, M., Butterfield, D., Cornelius, C., & . (2010). Oxidative damage in rat brain during aging: interplay between energy and metabolic key target proteins. Neurochemical Research, 35(12), 2184-92. https://doi.org/10.1007/s11064-010-0295-z (Original work published 2010)
